The preparation, characterisation and in vitro cytotoxicity of potentially chemotherapeutic heterobimetallic complexes containing early and late transition metals

Journal of Inorganic Biochemistry

Volumn 95, Issue 2-3, 2003, Pages 149-156

  Wedgwood, Janet L ^a   Kresinski, Roman A ^b   Merry, Stephen ^c   Platt, Andrew W G ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

^c STAFFORDSHIRE UNIVERSITY   (United Kingdom)

Author keywords

Characterisation; Chemotherapeutic heterobimetallic complexes; Early late transition metals; In vitro cytotoxicity

Indexed keywords

1,5 CYCLOOCTADIENE; ALKENE DERIVATIVE; ANTIINFECTIVE AGENT; CYCLOPENTADIENE DERIVATIVE; DICHLOROMETHANE; DIMETHYL SULFOXIDE; EDETATE SODIUM; EDETIC ACID; PLATINUM COMPLEX; SODIUM CHLORIDE; TITANIUM DERIVATIVE; UNCLASSIFIED DRUG; WATER; ZIRCONIUM DERIVATIVE; ZIRCONOCENE; ZIRCONOCENE DICHLORIDE;

AQUEOUS SOLUTION; ARTICLE; COLONY FORMATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; IONIZATION; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

GADUS MORHUA;

EID: 0038576428     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00097-7     Document Type: Article

References (25)

1. Wedgwood J.L., Hunter A.P., Kresinski R.A., Platt A.W.G., Stein B.K. Inorg. Chim. Acta. 290:1999;189-196.
2. Wheatley N., Kalck P. Chem. Rev. 99:1999;3379-3419.
3. Berardini M., Emge T.J., Brennan J.G. Inorg. Chem. 32:1993;2724-2728.
4. Baxter S.M., Ferguson G.S., Wolczanski P.T. J. Am. Chem. Soc. 110:1988;4231-4241.
5. B. Wenzel, P. Lönnecke, M. Stender, E. Hey-Hawkins, J. Chem. Soc. Dalton Trans. (2002) 478-480.
6. P.J. Stang, N.E. Persky, J. Chem. Soc. Chem. Commun. (1997) 77-78.
7. Wong E., Giandomenico C.M. Chem. Rev. 99:1999;2451-2466.
8. T.W. Hambley, J. Chem. Soc. Dalton Trans. (2001) 2711-2718.
9. Kopf H., Kopf-Maier P. Angew. Chem. Int. Ed. 18:1979;477-478.
10. M. Guo, P.J. Sadler, J. Chem. Soc. Dalton Trans. (2000) 7-9.
11. Aubrecht J., Krishna Narla R., Ghosh P., Stanek J., Uckun F.M. Toxicol. Appl. Pharmacol. 154:1999;228-235.
12. Harding M.M., Mokdsi G., Mackay J.P., Prodigalidad M., Wright Lucas S. Inorg. Chem. 37:1998;2432-2437.
13. Harding M.M., Mokdsi G. Curr. Med. Chem. 7:2000;1289-1303.
14. Yang P., Guo M. Coord. Chem. Rev. 185-186:1999;189-211.
15. Toney J.H., Marks T.J. J. Am. Chem. Soc. 107:1985;947-953.
16. Mokdsi G., Harding M.M. J. Inorg. Biochem. 86:2001;611-616.
17. Friedrich H.B., Moss J.R., Williamson B.K. J. Organomet. Chem. 394:1990;313-327.
18. S.J.S. Kerrison, P.J. Sadler, J. Chem. Soc. Chem. Commun. (1977) 861-863.
19. Sundquist W.I., Ahmed K.J., Hollis L.S., Lippard S.J. Inorg. Chem. 26:1987;1524-1528.
20. Gandolfi O., Blum J., Mandelbaum-Shavit F. Inorg. Chim. Acta. 91:1984;257-261.
21. Wappes B., Jennerwein M., von Angerer E., Schonenberger H., Engel J., Berger M., Wrobel K.-H. J. Med. Chem. 27:1984;1280-1286.
22. Mokdsi G., Harding M.M. Metal Based Drugs. 5:1998;207-215.
23. Farrell N., Kiley D.M., Schmidt W., Hacker M.P. Inorg. Chem. 29:1990;397-403.
24. Chen T.R. Exp. Cell Res. 104:1977;255-262.
25. Merry S., Flanigan P., Schlick E., Freshney R.I., Kaye S.B. Br. J. Cancer. 59:1989;895-897.